Anxiety Depression and Rheumatoid Arthritis

The Effect of Anxiety and Depression on Treatment Response in Rheumatoid Arthritis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03061877

Acronym

ADAR

Enrollment

134

Registered

2017-02-23

Start date

2019-09-30

Completion date

2021-12-31

Last updated

2018-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

Rheumatoid arthritis, Anxiety, Depression

Brief summary

Anxiety and depression are highly prevalent in people with rheumatoid arthritis (RA).This study is to investigate the effect of anxiety and depression on treatment response in people with RA using observational longitudinal study design.

Interventions

OTHERAnxiety or depression

The presence of anxiety or depression measured by the Hospital Anxiety and Depression Scale (HAD)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* People diagnosed with rheumatoid arthritis according to the American College Rheumatology (ACR) criteria 2010

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Clinical remission	6 months	Clinical remission defined by the Disease Activity Score 28 (DAS28) with a score less than 2.6

Contacts

Primary ContactKun Zou, PhD

zoukun.jy@outlook.com86 028-87393972

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026